Riskpilot← Back to searchSign inGet full accessHelkropsMR.dk ApS
APSActiveCVR 40414827Frederiks Plads 18Medical specialists activities · NACE 8622Est. 201916 employees
Revenue 2025
DKK 9,3M
-1% vs 2024
EBITDA margin
27.3%
-26% vs 2024
Equity ratio
53.4%
Financial strength
Net profit 2025
DKK 1,8M
-5% vs 2024
| Revenue | DKK 9,3M | -1% |
| EBITDA | DKK 2,6M | -26% |
| Net profit | DKK 1,8M | -5% |
| Total assets | DKK 3,5M | -21% |
| Equity | DKK 1,9M | -2% |
| Employees | 16 | — |
Legal name
HelkropsMR.dk ApS
CVR number
40414827
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
2. april 2019
Share capital
DKK 50.000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen i fællesskab.
Company purpose
Virksomhedens formål er at drive sundhedsklinik og virksomhed, der er naturligt forbundet hermed.
Address
Frederiks Plads 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7.137 | 11.842 | 8.362 | 9.382 | 9.334 |
| Staff expenses | -5.405 | -6.348 | -5.521 | -5.920 | -6.784 |
| EBITDA | 1.731 | 5.494 | 2.841 | 3.461 | 2.550 |
| Depreciation & amort. | -1.536 | -1.723 | -1.727 | -1.444 | -191 |
| EBIT | 195 | 3.772 | 1.114 | 2.017 | 2.359 |
| Net financials | -155 | -107 | 434 | 354 | -90 |
| Profit before tax | 41 | 3.665 | 1.549 | 2.371 | 2.269 |
| Tax | 11 | 806 | 349 | 524 | 506 |
| Net profit | 29 | 2.859 | 1.200 | 1.847 | 1.763 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7.276 | 9.658 | 8.540 | 4.427 | 3.504 |
| Equity | 217 | 2.962 | 2.162 | 1.909 | 1.872 |
| Long-term debt | 2.372 | 0 | 1.369 | 0 | 0 |
| Short-term debt | 4.596 | 6.609 | 6.293 | 2.442 | 1.591 |
| Total debt | 6.968 | 6.609 | 6.293 | 2.442 | 1.591 |
EBITDA margin
27.3%
This company
15.8%
Market median
+73% vs market
20212025
Equity ratio
53.4%
This company
38.2%
Market median
+40% vs market
20212025
Return on equity
94.2%
This company
18.4%
Market median
+412% vs market
20212025
Net profit margin
18.9%
This company
8.1%
Market median
+133% vs market
20212025
Asset turnover
2.66×
This company
1.12×
Market median
+138% vs market
20212025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JM Management | Management | 2019 |
JØ Management | Management | 2019 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2019 | |
| Company | 50–66.65% | 50–66.65% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MULLE II HOLDING ApS
HelkropsMR.dk ApS Board members of HelkropsMR.dk ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Mikkelsen | Management | 0 companies |
| Jesper Østergaard | Management | 0 companies |